An Unnoticed Case; Hypermagnesemia at the Emergency Department

Introduction. Hypermagnesemia gener-ally develops in people with renal function disorders or due to exogen Mg intake for constipation. Hospitalized cases of fatal hypermagnesemia are rare in the litera-ture. The aim of this case report was to see if fatal progression could be due to delayed diagnose.

Case Presentation. A 61 year old woman presented at the emergency department (ED) for the evaluation of her symptoms which were leg pain, weakness, nausea, constipation and general debility. In her prior history, she had used magnesia cal-cine for laxative until two weeks before. Electrocardiography showed atrial fi-brillation with high ventricular respond (HVRAF). Initial serum magnesium (Mg) concentration was 6.80 mEq/l. 10% cal-cium gluconate with 20 ml used to antago-nize symptoms for treatment. Intravenous (IV) metoprolol was used for HVRAF but the patient was unresponsive. On the second day Mg rose to 7.06 mEq/l. The patient’s consciousness was altered, she developed lethargy, and hemodynamic in-stability was revealed. In addition, respira-tory distress was present and patient was intubated. Therefore, she was diagnosed with a suspected Mg intoxication due to laxative use. Continuous hemodiafiltration (CHDF) was urgently used to decrease Mg. On the third day the patient was unrespon-sive to the treatment and died in intensive care unit (ICU).

Conclusion. Patients with nonspecific symptoms due to a prolonged laxative use can be admitted to the ED. Hypotension, altering consciousness and cardiac dysthy-mias can be revealed quickly and therefore the progress is fatal. Mg intoxication must be noticed early in the ED. IV calcium directly antagonises the effects of magne-sium. It can reverse effects such as cardiac arrhythmias. IV normal saline must be used for supportive treatment and if those not responding to intravenous calcium and other supportive measures, CHDF must be used urgently for all patients with features of life threatening hypermagnesemia.

Emergency Department, Laxa-tive, Hypermagnesemia

1. Van Hook JW. Endocrine crises. Hypermagnesemia. Crit Care Clin [Internet]. 1991 Jan [cited 2018 Sep 19];7(1):215–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2007216

2. Schelling JR. Fatal hypermagnesemia. Clin Nephrol [Internet]. 2000 Jan [cited 2018 Sep 19];53(1):61–5. Available from: http://www. ncbi.nlm.nih.gov/pubmed/10661484

3. So M, Ito H, Sobue K, Tsuda T, Katsuya H. Circulatory collapse caused by unnoticed hypermagnesemia in a hospitalized patient. J Anesth [Internet]. 2007 May 30 [cited 2018 Sep 19];21(2):273–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17458660

4. McLaughlin SA, McKinney PE. Antacid-Induced Hypermagnesemia in a Patient with Normal Renal Function and Bowel Obstruc-tion. Ann Pharmacother [Internet]. 1998 Mar 28 [cited 2018 Sep 19];32(3):312–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9533062

5. Dai LJ, Quamme GA. Intracellular Mg2+ and magnesium depletion in isolated renal thick ascending limb cells. J Clin Invest [Inter-net]. 1991 Oct 1 [cited 2018 Sep 19];88(4):1255–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1655827

6. Wyskida K, Witkowicz J, Chudek J, Więcek A. Daily Magnesium Intake and Hypermagnesemia in Hemodialysis Patients With Chronic Kidney Disease. J Ren Nutr [Internet]. 2012 Jan [cited 2018 Sep 19];22(1):19–26. Available from: http://www.ncbi.nlm.nih. gov/pubmed/21620724

7. Randall Re, Cohen Md, Spray Cc, Rossmeisl Ec. Hypermagnesemia In Renal Failure. Etiology And Toxic Manifestations. Ann Intern Med [Internet]. 1964 Jul [Cited 2018 Sep 19];61:73–88. Available From: Http://Www.Ncbi.Nlm.Nih.Gov/Pubmed/14178364

8. Monif GR, Savory J. Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA [Internet]. 1972 Mar 13 [cited 2018 Sep 19];219(11):1469–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/5066903

9. Weng Y-M, Chen S-Y, Chen H-C, Yu J-H, Wang S-H. Hypermagnesemia in a Constipated Female. J Emerg Med [Internet]. 2013 Jan [cited 2018 Sep 19];44(1):e57–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22244603

10. Agus ZS, Morad M. Modulation of Cardiac ION Channels by Magnesium. Annu Rev Physiol [Internet]. 1991 Oct [cited 2018 Sep 20];53(1):299–307. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1710436

11. Sontia B, Montezano ACI, Paravicini T, Tabet F, Touyz RM. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertens (Dallas, Tex 1979) [Internet]. 2008 Apr 1 [cited 2018 Sep 19];51(4):915–21. Available from: http://hyper.ahajournals.org/cgi/doi/10.1161/HYPERTENSIONAHA.107.100339

12. Navarro-González JF. Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol [Internet]. 1998 Jun [cited 2018 Sep 19];49(6):373–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9696434

13. Sugiyama M, Kusumoto E, Ota M, Kimura Y, Tsutsumi N, Oki E, et al. Induction of potentially lethal hypermagnesemia, ischemic colitis, and toxic megacolon by a preoperative mechanical bowel preparation: report of a case. Surg case reports [Internet]. 2016 Dec [cited 2018 Sep 19];2(1):18. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26943694